Last reviewed · How we verify

NCT05478616

Expression of Endometrium During Window of Implantation

Terminated Last updated 5 August 2024
What this trial tests

trial in Unrecognized Condition in 3 participants. Terminated before completion.

Timeline
1 July 2022
Primary endpoint
31 December 2023
31 December 2023

Quick facts

Lead sponsorKaohsiung Veterans General Hospital.
StatusTerminated
Study typeOBSERVATIONAL
Enrollment3
Start date1 July 2022
Primary completion31 December 2023
Estimated completion31 December 2023
Sites1 location across Taiwan

Conditions studied

Sponsor

Kaohsiung Veterans General Hospital.

Who can join

Adults 30 to 44, female only, with Unrecognized Condition. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study was to investigate the expression of endometrium during window of implantation between natural cycles and artificial cycles.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Unrecognized Condition

Currently open trials in the same condition.

Other Kaohsiung Veterans General Hospital. trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05478616.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing